Metastatic Bronchopulmonary Cancer
Conditions
Brief summary
Venous thrombo-embolism (VTE) is a frequent and serious complication of cancer. However, predictive tools for VTE in cancer patients is lacking. In patients with metastatic broncho-pulmonarycancer, biochemical characteristics might help to identify patients at high risk for VTE. The aim of this study is to derive a predictive score combining clinical and biochemical variable that predict VTE in metastatic broncho-pulmonary cancer.
Detailed description
Venous thrombo-embolism (VTE) is a frequent and serious complication of cancer. However, predictive tools for VTE in cancer patients is lacking. In patients with metastatic broncho-pulmonarycancer, biochemical characteristics might help to identify patients at high risk for VTE, particularly in adenocarcinoma. The aim of this study is to derive a predictive score combining clinical and biochemical variable that predict VTE in metastatic broncho-pulmonary cancer.
Interventions
None listed
Sponsors
University Hospital, Brest
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* metastatic broncho-pulmonary cancer * age ≥18 years * who are eligible for chemotherapy * non opposition obtained
Exclusion criteria
* age \<18 years * pregnancy, breast feeding * VTE in the past 6 months or at the time of cancer diagnosis * surgery in the past 3 months * refusal to participate
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| venous thromboembolism at 12 months | 12 months | objectively diagnosed VTE based on validated diagnostic tests |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| overall survival | one year | overall survival |
| survival without progression | one year | survival without progression |
| VTE at 6 months | 6 months | VTE at 6 months |
Countries
France
Contacts
Primary ContactFrancis COUTURAUD
Outcome results
None listed